https://en.m.wikipedia.org/wiki/Pembrolizumab
The promise of mRNA is the potential to prompt the body to produce the therapeutic antibodies itself, rather than produce them externally and injecting regularly.
No, it really isn't more than that. You could send mRNA code into the body that produces a designer antibody that is specific to the cancer a patient has (similar to CAR-T, Keytruda, etc.), or you could design mRNA that specifically causes cancer cells to express antigens that attract the immune system. I'm obviously oversimplifying a pinnacle of human achievement, but on paper it should work that way.
If you can find specific sites, you can design a complimentary piece of RNA code to bind it and allow the drug delivery mechanism to do it's thing. Way fewer side effects versus systemic delivery.
The article does explicitly call it a "cancer vaccine" (direct quote from the researcher) and says "the same principle [as the COVID-19 vaccine] can be applied to get the immune system to take on tumours".
That's more specific than sneaking in with mRNA to get the body to produce something. It definitely sounds like whatever it is, it gets the immune system involved. It seems fair to ask exactly how it does this.